Development Level

Tbio 46 | 11,651
Tchem 9 | 1,388
Tclin 2 | 612

IMPC Phenotype

preweaning lethality, complete... 3 | 979
abnormal embryo size 2 | 220
decreased circulating glucose ... 2 | 126
decreased erythrocyte cell num... 2 | 62
embryonic lethality prior to o... 2 | 239
embryonic lethality prior to t... 2 | 278
small testis 2 | 58
abnormal behavior 1 | 298
abnormal bone structure 1 | 187
abnormal cornea morphology 1 | 31
abnormal gait 1 | 69
abnormal locomotor behavior 1 | 24
abnormal lung morphology 1 | 26
abnormal skin coloration 1 | 25
abnormal urinary bladder morph... 1 | 11
decreased IgE level 1 | 6
decreased NK T cell number 1 | 2
decreased basophil cell number 1 | 16
decreased blood urea nitrogen ... 1 | 51
decreased circulating choleste... 1 | 93
decreased eosinophil cell numb... 1 | 24
decreased hemoglobin content 1 | 68
decreased lean body mass 1 | 135
decreased mean corpuscular vol... 1 | 79
decreased startle reflex 1 | 75
decreased total body fat amoun... 1 | 207
decreased vertical activity 1 | 208
edema 1 | 59
embryonic growth retardation 1 | 106
female infertility 1 | 60
hypoactivity 1 | 132
increased bone mineral content 1 | 108
increased circulating phosphat... 1 | 26
increased fasted circulating g... 1 | 76
increased lean body mass 1 | 172
increased mean corpuscular hem... 1 | 96
increased mean corpuscular vol... 1 | 92
increased spleen weight 1 | 10
male infertility 1 | 123
pallor 1 | 34
preweaning lethality, incomple... 1 | 499
prolonged QT interval 1 | 38
prolonged ST segment 1 | 36
thrombocytosis 1 | 27

Disease

osteosarcoma 39 | 7,950
ovarian cancer 38 | 8,520
Carcinoma 36 | 11,493
atypical teratoid / rhabdoid tumor 31 | 5,112
glioblastoma 31 | 5,792
medulloblastoma, large-cell 31 | 6,241
lung cancer 27 | 4,740
ependymoma 24 | 4,679
psoriasis 24 | 6,694
Cancer 20 | 2,499
primitive neuroectodermal tumor 19 | 3,035
intraductal papillary-mucinous neoplasm (IPMN) 17 | 3,291
Breast cancer 16 | 3,578
group 3 medulloblastoma 15 | 4,104
lung adenocarcinoma 15 | 2,716
adult high grade glioma 14 | 3,801
malignant mesothelioma 14 | 3,232
Astrocytoma, Pilocytic 13 | 3,081
astrocytoma 13 | 1,146
invasive ductal carcinoma 13 | 2,951
non-small cell lung cancer 13 | 2,890
oligodendroglioma 13 | 2,850
Kidney cancer 12 | 2,613
Multiple myeloma 12 | 1,332
dermatomyositis 11 | 966
intraductal papillary-mucinous carcinoma (IPMC) 11 | 2,989
pancreatic ductal adenocarcinoma liver metastasis 11 | 1,962
Waldenstrons macroglobulinemia 10 | 765
intraductal papillary-mucinous adenoma (IPMA) 10 | 2,955
pancreatic cancer 10 | 2,398
pediatric high grade glioma 10 | 1,064
Amyotrophic lateral sclerosis 9 | 451
Pick disease 9 | 1,894
adrenocortical carcinoma 9 | 1,428
group 4 medulloblastoma 9 | 1,855
tuberculosis 9 | 2,010
astrocytic glioma 8 | 2,597
diabetes mellitus 8 | 1,728
acute quadriplegic myopathy 7 | 1,158
colon cancer 7 | 1,478
ductal carcinoma in situ 7 | 1,745
pituitary cancer 7 | 1,972
Breast Neoplasms 6 | 445
Intellectual disability 6 | 1,016
Mammary Neoplasms 6 | 425
Renal Cell Carcinoma 6 | 214
nasopharyngeal carcinoma 6 | 1,058
progressive supranuclear palsy 6 | 676
Adenocarcinoma of lung 5 | 142
Autosomal recessive predisposition 5 | 1,442
Disease Models, Animal 5 | 155
Gaucher disease type 1 5 | 180
breast carcinoma 5 | 1,638
cystic fibrosis 5 | 1,696
esophageal adenocarcinoma 5 | 737
interstitial cystitis 5 | 2,312
juvenile dermatomyositis 5 | 1,187
spina bifida 5 | 1,074
subependymal giant cell astrocytoma 5 | 2,287
Carcinoma, Hepatocellular 4 | 228
Carcinoma, Renal Cell 4 | 124
Carcinoma, Squamous Cell 4 | 110
Cognitive delay 4 | 608
Colorectal Neoplasms 4 | 243
Down syndrome 4 | 499
Dull intelligence 4 | 645
Fragile X syndrome 4 | 34
Global developmental delay 4 | 608
Infertility 4 | 188
Liver carcinoma 4 | 240
Low intelligence 4 | 645
Lung Neoplasms 4 | 232
Mental Retardation 4 | 645
Mental and motor retardation 4 | 608
Mental deficiency 4 | 645
Mesothelioma, Malignant 4 | 105
Poor school performance 4 | 645
Prostatic Neoplasms 4 | 495
Rheumatoid arthritis 4 | 1,191
Squamous cell carcinoma 4 | 129
autosomal dominant Emery-Dreifuss muscular dystrophy 4 | 510
lung carcinoma 4 | 2,843
non primary Sjogren syndrome sicca 4 | 891
primary pancreatic ductal adenocarcinoma 4 | 1,109
tuberculosis and treatment for 6 months 4 | 409
ulcerative colitis 4 | 1,819
Endometriosis 3 | 540
Hepatomegaly 3 | 285
Liver cancer 3 | 604
Mouth Neoplasms 3 | 55
Myocardial Ischemia 3 | 169
Neoplasm Invasiveness 3 | 161
Neurodegenerative disease 3 | 414
Schizophrenia 3 | 1,160
Short stature 3 | 531
acute myeloid leukemia 3 | 783
cutaneous lupus erythematosus 3 | 1,057
medulloblastoma 3 | 720
nephrosclerosis 3 | 333
sonic hedgehog group medulloblastoma 3 | 467

Tissue

Blood and immune system 55 | 16,909
Endocrine System 55 | 18,159
Female tissues 55 | 17,400
Liver and Pancreas 54 | 16,750
Respiratory system 54 | 16,393
Digestive Tract 53 | 17,369
Male tissues 53 | 17,142
Nervous System 53 | 16,725
Skin and soft tissues 53 | 17,230
Urinary Tract 53 | 16,678
Cardiovascular System 50 | 15,192

Target Family

Non-IDG 38 | 12,091
Enzyme 11 | 4,145
Kinase 4 | 634
Transcription Factor 3 | 1,400
Epigenetic 1 | 242

GO Process

negative regulation of transla... 57 | 57
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Eukaryotic translation initiation factor 4E transporter EIF4ENIF1 Tbio Non-IDG -1.60874 36.7 242
Nucleolysin TIA-1 isoform p40 TIA1 Tbio Non-IDG -2.86461 714.2 314
Calreticulin CALR Tbio Non-IDG -3.19563 1544.2 778
RNA-binding protein 4 RBM4 Tbio Non-IDG -1.71130 51.9 162
Fragile X mental retardation syndrome-related protein 2 FXR2 Tbio Epigenetic -1.35956 16.3 219
Receptor of activated protein C kinase 1 RACK1 Tbio Non-IDG -2.60480 437.9 300
2-iminobutanoate/2-iminopropanoate deaminase RIDA Tbio Enzyme -1.74722 52.8 104
Glyceraldehyde-3-phosphate dehydrogenase GAPDH Tchem Enzyme -3.68189 4548.4 1886
Protein Smaug homolog 2 SAMD4B Tbio Non-IDG -0.93281 9.61 103
Proteoglycan 3 PRG3 Tbio Non-IDG -1.00718 11.4 37